This site is intended for health professionals only

Home / News / Latest News / MHRA warns against homeopathic teething products

MHRA warns against homeopathic teething products


11 Oct 2016

The MHRA has warned parents against using unlicensed homeopathic teething products due to a risk of seizures and other serious side effects.

The agency’s advice comes after the US Food and Drug Administration (FDA) launched an investigation into homeopathic teething gels and tablets manufactured in the US, which could be available to buy online in the UK.

A number of serious side effects have been linked with the products in question, including fits, breathing problems, lethargy, excessive sleepiness, muscle weakness, problems urinating, agitation and skin flushing.

The products being investigated are not thought to be on sale in UK outlets but might be available online.

The National Institute for Health and Care Excellence recommends self-care for teething infants, involving gentle rubbing of the gum and allowing the child to bite on a clean, cool object. Paracetamol or ibuprofen can be administered for those aged three months and older.

Pharmacists are being urged to reassure parents that teething treatments licenced in the UK are unaffected.

The following homeopathic products are licenced by the MHRA and can continue to be used:

Authorisation Number Product Name Authorisation Holder Company Name
NR 01175/0184 TEETHA TEETHING GEL A NELSON AND COMPANY LIMITED
NR 01175/0387 NELSONS TEETHA TEETHING GRANULESBOOTS TEETHING PAIN RELIEF A NELSON AND COMPANY LIMITED
NR 08822/0250 CAMILIA ORAL SOLUTION BOIRON
NR 27776/0003 HELIOS ABC 30C PILLULES HELIOS HOMOEOPATHY LIMITED
PLR 00298/5826 WELEDA CHAMOMILLA 3X GRANULES WELEDA UK LIMITED

By Allie Anderson


Want news like this straight to your inbox?


Latest News

Plans to allow pharmacists to administer Covid-19 vaccine become law
Community pharmacists will be able to administer Covid-19 vaccines under amendments to the Human Medicines...
Serious shortage protocol for Fluoxetine 40mg capsules ends
The serious shortage protocol (SSP) issued in response to ‘significant ongoing disruption to the supply...
Plans to withdraw widely-used bipolar drug put on hold
A drug company that recently increased the price of a bipolar drug, while also proposing...